For the development of AP, low interleukin-10 levels lead to an enhanced release of pro-inflammatory cytokines, such as tumor necrosis factor-alpha, which have been implicated in alveolar bone loss [29, 58]. This evidence concerns the gene IL10 and alkaline phosphatase measurement.